Diagnostic biomarker analysis adjusted for the time of onset of cGVHD on metabolomic biomarker patterns. We compared plasma samples (n = 40) at onset of cGVHD at any time point to all samples (n = 491) from subjects enrolled on the study. The identical identifying metabolic color code and selection criteria as in Figure 1 were used in this figure.